Alopecia Areata: all 469 studies

Page 3 of 5. Open to participants first (91), then studies with results posted, then the rest; newest registration first within each.

• A Study of DR-01 in Subjects With Alopecia Areata and VitiligoActive, not recruitingNCT06602232Phase 1
• A Clinical Trial to Examine the Efficacy of a Supplement to Support Healthy Hair and SkinActive, not recruitingNCT06579742Not applicable
• Study Evaluating the Efficacy and Safety of BENEV Exosome Regenerative Complex+ for Self-perceived Thinning HairCompletedNCT06571799Not applicable
• Clinical Trial on the Efficacy of Intralesional Triamcinolone Versus Candida Albicans Antigen in Treating Alopecia AreataStatus unknownNCT06564805Not applicable
• Efficacy and Safety of a Dietary Supplement on Hair Growth and Hair Health in Female With Acute Telogen EffluviumCompletedNCT06545552Not applicable
• Retinol Binding Protein 4 Protein in Alopecia Areata Treated With BarcitinibActive, not recruitingNCT06545110Phase 1
• Characterization And Clinical Outcomes of AA Patients Treated With RitlecitinibActive, not recruitingNCT06531109
• A Novel Formulation of Sildenafil-loaded Nanocarriers for Treatment of Alopecia AreataCompletedNCT06527729Early Phase 1
• A Clinical Trial to Examine the Efficacy of a Dietary Supplement to Improve the Health and Appearance of Hair.Active, not recruitingNCT06515496Not applicable
• a Retrospective Study on the Systemic Treatment of LPP and FFACompletedNCT06512766
• Clinical Study of Probiotic Treatment for Androgenetic AlopeciaWithdrawnNCT06484881Phase 3
• Evaluation of the Efficacy of Systemic Treatments for Alopecia (ESTAA)Active, not recruitingNCT06471114
• A Study to Evaluate the Efficacy and Safety of Subcutaneous Amlitelimab Monotherapy Compared With Placebo in Adult Participants With Severe Alopecia AreataTerminatedNCT06444451Phase 2
• To Evaluate Safety and Efficacy of KX-826 in Chinese Female Subjects With Androgenetic AlopeciaCompletedNCT06409650Phase 2
• A Phase 2 Placebo Controlled, Clinical Trial Designed to Assess the Efficacy, Safety and Dose Response Characterisation of STS01 for the Treatment of Mild-moderate Alopecia Areata (AA)CompletedNCT06402630Phase 2
• Evaluation of an Oral Hair Supplement to Improve Hair Strength and Support Growth in Women and MenCompletedNCT06362941Not applicable
• A Phase 2b Study to Evaluate Rezpegaldesleukin (Rezpeg) in the Treatment of Severe to Very Severe Alopecia Areata in Adult Patients (Rezolve AA)CompletedNCT06340360Phase 2
• Development and EValuation of an Online Intervention to Reduce Self-Stigma in People With Visible Chronic Skin disEasesCompletedNCT06324695Not applicable
• Litfulo Capsules Special InvestigationActive, not recruitingNCT06279221
• Efficacy of Oral Tofacitinib in Moderate to Severe Alopecia Areata, Totalis and Universalis at Tertiary Care Hospital, Karachi.CompletedNCT06278402Phase 3
• Efficacy and Safety of Exosomes Versus Platelet Rich Plasma in Patients of Androgenetic AlopeciaCompletedNCT06239207Phase 2
• The Effect of 24-week Dietary Intake of Food Supplements on HairCompletedNCT06174441Not applicable
• Efficacy and Safety of Oral Tofacitinib in the Treatment of Alopecia AreataCompletedNCT06157905Early Phase 1
• The Effects of an Oral Hair Supplement on Hair Density, Growth, and MicrobiomeActive, not recruitingNCT06146166Not applicable
• Phase III Study of KX-826 With Adult Male Patients With AGAActive, not recruitingNCT06126965Phase 3
• A Study to Assess the Efficacy and Safety of HMI-115 in Male Subjects With Androgenetic AlopeciaCompletedNCT06118866Phase 2
• Keravive by Hydrafacial for Scalp Health and Enhanced Hair QualityCompletedNCT06112782Not applicable
• Hair Regeneration in Androgenetic AlopeciaActive, not recruitingNCT06066827Not applicable
• Impact of a Topical Cosmetic Product on Women's HairCompletedNCT06060834Not applicable
• A First in Human Single and Multiple Ascending Dose and Open Label Food Effect Study of OR-101 in Healthy SubjectsWithdrawnNCT06045624Phase 1
• Effectiveness and Safety of Platelet-rich Plasma and Topical 5% Minoxidil Combination in Male Androgenetic AlopeciaActive, not recruitingNCT06043349Phase 4
• A Phase 2a Proof-of-Concept Trial of Bempikibart (ADX-914) for the Treatment of Severe Alopecia Areata (SIGNAL-AA)Active, not recruitingNCT06018428Phase 2
• Effectiveness of Combination Therapy of Microneedling and Minoxidil in Androgenetic Alopecia of Indonesian MenCompletedNCT05989165Phase 3
• A Clinical Study to Assess the Safety and Effectiveness of Plant-based Biotin and Plant Based Biotin with Silica in Healthy Human Subjects with Complaints of Hair Fall, Thin, Dry, & Brittle Hair, and Dry SkinCompletedNCT05972512Not applicable
• Assessing the Safety and Efficacy of a Novel Microneedling and Laser Device for Male Pattern Hair LossCompletedNCT05970809Not applicable
• Evaluation of the Effect of Topical Calcipotriol Versus Platelet-Rich PlasmaCompletedNCT05954104Not applicable
• Evaluation of the Efficacy of a New Supplement for Hair and Nails - in Vitro, Clinical, Subjective and Instrumental StudyCompletedNCT05945979Not applicable
• Efficacy and Tolerability of Pantovigar® Vegan in Female Subjects With Diffuse Hair LossCompletedNCT05943860Not applicable
• Phase II Study Evaluating the Efficacy and Safety of KX-826CompletedNCT05940506Phase 2
• Efficacy of Oral Apremilast in the Treatment of Alopecia Areata at the Tertiary Care Hospital, Karachi.CompletedNCT05926882Phase 4
• Comparative Efficacy of Tacrolimus and Clobetasol Propionate in Alopecia AreataCompletedNCT05885269Phase 1
• A Clinical Observation of 1565nm Non-ablative Fractional Laser in the Treatment of Androgenic AlopeciaStatus unknownNCT05827991Not applicable
• Topical Cetirizine in Treatment of Localized Alopecia AreataStatus unknownNCT05803070
• A Clinical Study to Assess the Safety and Effectiveness of Plant Based Biotin in Healthy Human Subjects With Thin, Dry, and Brittle HairCompletedNCT05800496Not applicable
• Study of the Characteristics of Pruritus in Patients With Frontal Fibrosing Alopecia or Lichen Planus PilarisTerminatedNCT05761158
• 1565nm Non-ablative Fractional Laser Treat Alopecia AreataStatus unknownNCT05744505Not applicable
• Comparing Platelet-Rich Plasma (PRP) Centrifugation Methods on Thrombocyte Concentration and Clinical Improvement of Androgenetic AlopeciaStatus unknownNCT05681897Not applicable
• A Phase 2 Study to Evaluate the Safety and Efficacy of CKD-498 in Female Patients With Androgenetic AlopeciaCompletedNCT05677438Phase 2
• Safety and Efficacy Study of Topical DLQ01 in the Treatment of Androgenetic Alopecia (AGA) in MenCompletedNCT05636904Phase 1/2
• Combined CO2 Fractional Laser With Bimatoprost 0.03% Treatment of Alopecia AreataCompletedNCT05600673Phase 1/2
• Clinical Trial to Evaluate Effectiveness of a Probiotic Preparation Administered to Patients With Alopecia AreataCompletedNCT05599607Not applicable
• Clinical Trial of Safety and Efficacy of Daily Application of Topical Dutasteride in Men With Androgenic Alopecia.CompletedNCT05599243Phase 2
• New Treatment of Alopecia AreataCompletedNCT05594316Not applicable
• Role of Minoxidil in Alopecia Areata Transepidermal Drug Delivery of Minoxidil Via Either Fractional Carbon Dioxide Laser or Microneedling Versus Its Topical Nanoparticles Preparation for Treatment of Alopecia AreataStatus unknownNCT05587257Not applicable
• Combined Microneedling and Topical Pentoxifylline Vesrus Intalesional Pentoxifylline in Treatment of Alopecia Areata: Intra-indiviual Comparative StudyStatus unknownNCT05502952Not applicable
• A Study of KL130008 in Adults With Severe Alopecia AreataTerminatedNCT05496426Phase 2
• Efficacy of Combined Microneedling With Methotrexate in Treatment of Alopecia AreataStatus unknownNCT05485571Not applicable
• Evaluate the Efficacy and Safety of SHR0302 in Adult Patients With Severe Alopecia AreataActive, not recruitingNCT05470413Phase 3
• Use of Botulinum Toxin in the Treatment of Androgenic AlopeciaActive, not recruitingNCT05456087Phase 2
• Effect of the Composition From Fish on Promoting Hair GrowthCompletedNCT05450861Not applicable
• Fractional Laser Versus Radiofrequency in Androgenetic AlopeciaStatus unknownNCT05435625Not applicable
• Hydraderm for Androgenic AlopeciaWithdrawnNCT05426629Phase 4
• Calcipotriol as a Novel Treatment for Central Centrifugal Cicatricial Alopecia (CCCA)WithdrawnNCT05416320Early Phase 1
• Study Evaluating Efficacy of Topical Squaric Acid Dibutyl Ester in Children and Adolescents With Alopecia AreataStatus unknownNCT05414266Early Phase 1
• Improving Disease SeverityCompletedNCT05391178Not applicable
• Comparison Between Efficacy of Topical Sildenafil 2% and Topical Minoxidil 5% in Treatment of Androgenic AlopeciaStatus unknownNCT05369481Not applicable
• A Pilot Study to Evaluate the Use of the AMMA Portable Scalp Cooling System From Cooler HeadsWithdrawnNCT05365243Not applicable
• Activated PRP for Treatment of Androgenetic AlopeciaCompletedNCT05348343Phase 1/2
• Nutraceutical Supplement With Standardized Botanicals in Males With Thinning HairCompletedNCT05339958Not applicable
• Nutraceutical Supplement With Vegan Botanicals in Females With Self-Perceived Thinning HairCompletedNCT05332743Not applicable
• To Evaluate the Safety, Tolerability and Efficacy in Male and Female with AGA Treated with HMI-115 Over a 24-week Treatment PeriodCompletedNCT05324293Phase 1
• Adipose-derived Stem Cell Conditioned Media as a Novel Approach for Hair Regrowth in Male Androgenetic AlopeciaCompletedNCT05296863Phase 3
• Extension Study to Evaluate Safety and Efficacy of Jaktinib in Adults With Alopecia AreataCompletedNCT05255237Phase 3
• Comparative Study Efficacy and Safety of of Activated Versus Non-Activated PRPCompletedNCT05251831Early Phase 1
• A Study of TDM-105795 in Male Subjects With Androgenetic Alopecia (AGA)CompletedNCT05244980Phase 1
• To Evaluate Efficacy, Safety, and Tolerability of KX-826 in Male Subjects With Androgenetic AlopeciaCompletedNCT05218642Phase 2
• Treatment of Alopecia Using Follicular Stem CellsStatus unknownNCT05210452Phase 1/2
• A Study to Evaluate the Efficacy and Safety of Rosnilimab (ANB030) in Treatment of Subjects With Moderate-to-Severe Alopecia AreataStatus unknownNCT05205070Phase 2
• A Study to Evaluate the Safety of MAX-40070 in Healthy SubjectsStatus unknownNCT05196711Phase 1
• Efficacy of Platelet-Rich Plasma Versus Mesotherapy in Androgenetic Alopecia: A Retrospective StudyCompletedNCT05129800
• Thulium Laser and Topical Platelet Rich Plasma (PRP) vs. PRP Injection for the Treatment of Male Androgenetic AlopeciaWithdrawnNCT05129254Not applicable
• The Epidemiology, Management and Comorbidities in Alopecia Areata in Czech RepublicCompletedNCT05098600
• Study to Evaluate the Safety and Efficacy of Jaktinib in Adults With Alopecia AreataCompletedNCT05051761Phase 3
• Oral Herbal Combination Formulation and Hair Growth in WomenWithdrawnNCT05019066Not applicable
• Sodium Valproate-loaded Nanospanlastics in Patchy Alopecia Areata in Comparison to Topical SteroidsCompletedNCT05017454Early Phase 1
• Safety, Tolerability and Pharmacokinetics of KX826 in Healthy Male Subjects With Androgenetic Alopecia Following Topical Single Ascending Dose AdministrationCompletedNCT04984707Phase 1
• Efficacy of Jessener Solution Versus Intralesional Steroid in Treatment of Alopecia AreataStatus unknownNCT04964349Early Phase 1
• A Phase 1 Study of TDM-105795 Topical Solution in Male Subjects With Androgenetic Alopecia (AGA)CompletedNCT04913519Phase 1
• LLLT for Alopecia of the Eyebrow in WomenCompletedNCT04897555Not applicable
• Evaluation of the Efficacy of a Food Supplement in Reducing Hair Loss in Male SubjectsCompletedNCT04884347Not applicable
• Thulium Laser and KeraFactor for the Treatment of Androgenetic AlopeciaWithdrawnNCT04882969Not applicable
• BL3000 Compared to Pantogar® in the Treatment of Telogen Effluvium in Women.Status unknownNCT04880889Phase 3
• Androgenetic Alopecia Treatment Using Varin and Cannabidiol Rich Topical Hemp Oil: A Case SeriesStatus unknownNCT04842383Early Phase 1
• COVID-19 Induced Telogen EffluviumStatus unknownNCT04834102
• Excimer Light and Topical Steroid in Treatment of Alopecia AreataStatus unknownNCT04793945Phase 4
• A Phase 2a Trial of FOL-005 Topical Formulations to Investigate Hair Growth Potential and Safety in Healthy Male VolunteersCompletedNCT04774874Phase 2
• A Study of JNJ-64304500 in Participants With Alopecia AreataWithdrawnNCT04740970Phase 2
• Superficial Cryotherapy Versus Microneedling in Alopecia AreataCompletedNCT04680234Not applicable
• Cooling Cap Trial to Prevent Permanent Chemotherapy-induced Alopecia in Breast Cancer PatientsCompletedNCT04678544Not applicable
• Intralesional Vitamin D in Alopecia AreataStatus unknownNCT04660786Phase 1/2

← Alopecia Areata overview